As of 2023, the Alimentary Tract and Metabolism Medicine sales in Canada were recorded at $6.00 billion. Over the forecasted period from 2024 to 2028, the market demonstrates a steady upward trend. In 2024, sales are expected to reach $6.36 billion, a 6% increase from the previous year. The growth continues with a rise of 7.7% in 2025, reaching $6.85 billion, followed by a 6.9% increase in 2026 to $7.32 billion, a 6.3% rise in 2027 to $7.78 billion, and a 5.5% increase in 2028, reaching $8.21 billion. The compound annual growth rate (CAGR) from 2024 to 2028 is approximately 6.7%.

Future trends to watch include:

Advancements in pharmaceutical technology and innovation driving demand.
Potential regulatory changes impacting market dynamics.
Economic factors influencing healthcare spending and investment in the sector.
The role of new treatment methods and personalized medicine in shaping market growth.